Wrong technique in product usage process: FDA reporting patterns
199,314 FDA FAERS reports mention Wrong technique in product usage process. 32,871 reports have a serious outcome flag.
Medicines named as suspect
- Evolocumab: 22,314 reports
- Albuterol: 18,460 reports
- Adalimumab: 12,170 reports
- Pegfilgrastim: 10,254 reports
- Etanercept: 10,082 reports
- Erenumab: 9,476 reports
- Valsartan: 9,033 reports
- Sacubitril: 8,080 reports
- Leuprolide: 5,469 reports
- Fluticasone: 3,794 reports
- Semaglutide: 3,233 reports
- Fentanyl: 2,873 reports
FAERS reports describe events reported after a medicine was taken. They do not prove that the medicine caused an event, measure how often a side effect occurs, or estimate personal risk.
Source: FDA FAERS via openFDA. FAERS data through 2026-06-30. Sources, methods, and limitations.